Approaches to Gene Modulation Therapy for ALS

Area of Science:

• Neuroscience
• Genetics
• Biotechnology

Background:

• Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease with limited therapeutic options.
• Understanding ALS genetics and disease mechanisms is crucial for developing effective treatments.

Purpose of the Study:

• To review recent clinical and preclinical advances in gene modulation therapies for ALS.
• To highlight the potential of gene silencing, correction, and augmentation strategies for ALS treatment.

Main Methods:

• Review of clinical trials and preclinical studies involving gene modulation for ALS.
• Focus on adeno-associated virus (AAV)-mediated microRNAs and antisense oligonucleotides (ASOs).
• Targeting common ALS genes such as SOD1, C9ORF72, FUS, and ATXN2.

Main Results:

• Six gene modulation therapies have been tested in ALS patients.
• These therapies target the gain-of-function pathology of specific ALS-associated genes.
• Gene modulation approaches show promise in preclinical and early clinical settings.

Conclusions:

• Gene modulation strategies represent a promising frontier for ALS therapy development.
• These approaches have the potential to significantly impact future research and clinical practice for ALS.
• Innovations in gene therapy could transform treatment outcomes for this devastating disease.